Skip to content

Resilience in Reentry: Cognitive-Behavioral Resilience Training for Parolees With Adjustment Challenges

Resilience in Reentry: Cognitive-Behavioral Resilience Training for Parolees With Adjustment Challenges

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07167719
Enrollment
60
Registered
2025-09-11
Start date
2026-01-27
Completion date
2026-12-01
Last updated
2026-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adjustment

Keywords

Incarceration, Reentry

Brief summary

This pilot study assesses the feasibility and acceptability of delivering a brief Cognitive-Behavioral Resiliency treatment to a population of recently released parolees. This study will also give a preliminary indication if the treatment is associated with reliable improvements in adjustment symptoms and well-being for parolees.

Detailed description

In the proposed pilot study, residents of a reentry facility in Los Angeles, CA will be able to enroll in a course of brief (5-session) Cognitive-Behavioral Therapy (CBT) focused on building resiliency in response to the effects of institutionalization. Those who choose to receive the intervention will be included in the intervention group (target N = 30). Those who choose not to receive the intervention will be given the opportunity to complete assessments at the same intervals as the intervention group (assessment only group; target N = 30). Participants will report their degree of satisfaction with the program and how much they think they benefitted from the program at postintervention. Participants will complete self-report measures of adjustment disorder symptoms, flourishing, meaning and purpose in life, and PTSD symptoms at pretreatment (baseline), posttreatment (5 weeks after baseline), and 2-month follow-up (13 weeks after baseline).

Interventions

BEHAVIORALCognitive Behavioral Therapy

Brief Cognitive-Behavioral Therapy (CBT) focused on building resiliency in response to the effects of institutionalization

Sponsors

University of California, Irvine
Lead SponsorOTHER
Massachusetts Institute of Technology (MIT)
CollaboratorUNKNOWN

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

The study employees two arms: the treatment arm and an assessment only arm. The pilot study is non-randomized.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years or older * Speaks English * Been on parole for two years or less. * Score of 8.5 or higher (range 4 to 16) on the Adjustment Disorder New Module 4 (ADNM-4) screening tool (Ben-Ezra, et al., 2018).

Exclusion criteria

None

Design outcomes

Primary

MeasureTime frameDescription
Adjustment Disorder New Module 20From pretreatment (baseline) to the end of treatment (5 weeks after baseline)The ADNM-20 is a self-report measure consisting of two parts: a stressor list and an item list. It is a 20-item measure that ranges from 20 to 80. Participants will fill out stressors from their prison term and will then complete the items which are composed of a 4-point Likert scales from "Never" to "Often."
Flourishing ScaleFrom pretreatment (baseline) to the end of treatment (5 weeks after baseline)The Flourishing Scale is an 8-item self-report measure (with a range of 8 to 56) of the respondent's self-perceived success in important areas such as relationships, self-esteem, purpose, and optimism. The scale provides a single psychological well-being score.
PROMIS Meaning and Purpose Short Form 8aFrom pretreatment (baseline) to the end of treatment (5 weeks after baseline)The PROMIS Meaning and Purpose is an 8-item self-report measure with a range of 8 to 40 that assess one's sense of life having purpose and that there are good reasons for living. Higher scores indicate hopefulness, optimism, goal-directedness, and feelings that one's life is worthy.

Secondary

MeasureTime frameDescription
PTSD Checklist 5From pretreatment (baseline) to the end of treatment (5 weeks after baseline)This is an 8-item abbreviated version of the PTSD Checklist 5, a self-report measure which ranges from 0 to 32 that assesses the DSM-5 symptoms of PTSD.

Countries

United States

Contacts

CONTACTJoanne B DeCaro
jdecaro@uci.edu360-903-5503
CONTACTAlyson K Zalta
azalta@uci.edu949-490-2247
STUDY_DIRECTOREmily Owens

University of California, Irvine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026